%0 Journal Article
%T Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model
%A Anne-Sophie W. M£żller
%A Lukasz Kuryk
%A Magnus Jaderberg
%J Archive of "Oncoimmunology".
%D 2019
%R 10.1080/2162402X.2018.1532763
%K ONCOS-102
%K Pembrolizumab
%K melanoma
%K NOG
%K immunogenic cell death
%K PD-1 inhibitor
%K antitumor
%K cancer vaccine
%K oncolytic adenovirus
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343802/